By Caroline Simson ( March 16, 2020, 5:28 PM EDT) -- An arbitrator weighing whether he can adjudicate biotechnology company Seattle Genetics Inc.'s dispute with Daiichi Sankyo Co. Ltd. over cancer drug patents will wait for recommendations from a Delaware court before deciding, according to the Japanese pharmaceutical company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.